Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China's Essential Drug Prices Less Severe Than Expected; Some Prices See Increases

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China's National Development and Reform Commission issued Oct. 2 a guideline price for its Essential Drug List, which stipulates price ceilings for 296 drugs on the first part of the list
Advertisement

Related Content

Merck And Simcere Trial Partnership In China: Two Different Cultures But One Common Goal
Will Differentiated Pricing Spread Across China?
China's Ministry Of Health To Release Guidance For Doctors On Most Commonly Used Drugs
China Healthcare Industry Will See A Strong 2010: Morgan Stanley
China Releases New Guidelines For Drug And Device Price Reforms
China's Health Reform Will Nurture New Drugs, And Boost Use Of Old Ones
China's Health Reform Will Nurture New Drugs, While Boosting Use Of Old Ones - PharmAsia Summit
China's Health Reform Will Nurture New Drugs, While Boosting Use Of Old Ones - PharmAsia Summit
Pharmaceutical Revenues In China Rising Faster Than Projected
China Releases First Part Of Essential Drug List For Community Health Clinics And Rural Hospitals
Advertisement
UsernamePublicRestriction

Register

SC070225

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel